What are Gwyneth Paltrow and Peter Thiel doing together?

March 09, 2021

peter thiel of thiel investors

ATAI Life Sciences, a Munich-based biotechnology company that aims to develop drugs to treat anxiety and depression, recently raised $157 million in a Series D funding round. The company develops both psychedelic drugs— like psilocybin mushrooms— and non-psychedelic drugs. ATAI, founded in 2018, has raised $367 million in total. Peter Thiel (pictured right) of Thiel Investors is one of the names behind ATAI.

gwyneth paltrow of goop inc

Who else is a fan of psilocybin? Actress Gwyneth Paltrow (pictured left) who not long ago took some of her Goop staffers on a magic mushroom retreat.

 


What did ResoluteAI discover about psilocybin "magic" mushrooms?

 

Psilocybin clinical trials:

Leading universities in the field of psilocybin are:

Leading researchers studying this area are:


Psilocybin and psilocybin mushrooms in the news

News on psilocybin and psilocybin mushrooms far outpaced news on fentanyl, heroin, and MDMA in 2020. There was also a spike in publications on psilocybin last year. See the charts below.

In the news
ResoluteAI analytics pshilocybin news

In publicationsResoluteAI analytics pshilocybin publications

What’s been at the forefront of psilocybin news? See below for a list of some articles.

Research across all of these databases was conducted quickly and efficiently using ResoluteAI’s Foundation. To talk to a real person about how Foundation can help your company or organization, please email us at info@resolute.ai.

Let's talk

Lesley Pink

Lesley Pink, our senior digital editor/writer, has written across a range of industries including artificial intelligence, actuarial science, government, law, and financial journalism. She's a fan of the serial comma and mint chocolate chip ice cream. And no, pink is not her favorite color. You can reach Lesley at lesley@resolute.ai.